Home > News > Flick of Switch Controls Medicine: Nanoparticle Drug Delivery
September 6th, 2010
Flick of Switch Controls Medicine: Nanoparticle Drug Delivery
Abstract:
A recent review gives an up-to-the-minute round-up of how mesoporous silica nanoparticles are used to deliver drugs into cells.
Most doctors would love to be able to inject a drug into a patient and to know that it will act directly and only on the source of the problem. The drug should not show up elsewhere in the body, or even cause problems there. Medics and patients alike want a treatment that can be controlled as exactly as possible, so that it delivers the right amount of the right drug, in the right place, and at the right time. This kind of targeted delivery reduces the possibility of side-effects, which are often caused by the drug acting on an unplanned part of the body. To these ends, scientists are working on delivery systems that can be switched on and off by using internal or external signals, are targeted to head for a specific signal, and are biocompatible so that they will not cause problems in the body. These developments could revolutionize the way that we receive treatment in hospital.
Source:
materialsviews.com
Bookmark:
| Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Possible Futures
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Academic/Education
Rice University launches Rice Synthetic Biology Institute to improve lives January 12th, 2024
Multi-institution, $4.6 million NSF grant to fund nanotechnology training September 9th, 2022
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Nanobiotechnology
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||